I would say that we know for certain, like with 10

I would say that we know for certain, like with 100% certainty, that Leronlimab works for certain people with covid.

There is no doubt about that. Its completely 100% certain.

Take for example the case report by Lalezari in his letter to Woodock.

89 days on ECMO if memory serves. Are you kidding me?

Three days after LL the patient is off ECMO.

That patient was also the husband of one of the scientists in the UK so that patient was likely treated like gold because the scientist knew every possible thing to try to help them get better, and no way the hospital docs are going to disagree with the medical scientist.

Then Samantha Mottet, like 40 days on ECMO and then off almost immediately with Leronlimab?

These kinds of patients are their own controls, and the control is better than any possible human clinical trial.

We know for certain that it works for some people.

That is 100% certain.

Why can't the knuckleheads at Cytodyn figure it out?

For CD12, did all the CD12 patients have the same results as the Montefiore patients: 14 day reduced viral load, 14 day reduced CCL5, 14 day near 100% receptor occupancy, 14 day restoration of normal CD4/CD8 ratios.

So are the CD12 patients the same as the Montefiore patients, yes or no?

Unfortunately, the answer is probably "We don't know cuz we didnt run the tests" or perhaps even worse "We did run the tests but Patterson won't give them to us cuz we wont pay him."

These are obvious, brainless questions that Cytodyn has never addressed.